Drug
AL18F clinical trials
Keep track of what changes. Save the AL18F studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Name
- Al18F-NOTA-FAPI
- 2
Studies by the year they started
4 studies that test it; most in 2021 (1)
| Year | Studies |
|---|---|
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 0 · Other 4
Cancer Institute and Hospital, Chinese Academy of Medical Sciences (3) · Peking Union Medical College Hospital (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses AL18F is read from its arms, and is right about nine times in ten.
Testing it · 4
- Predictive Value of Tumor Microenvironment PET/CT for Response and Prognosis in Aggressive LymphomaRecruitingNot applicableCancer Institute and Hospital, Chinese Academy of Medical SciencesNCT07657494Written as Al18F-NOTA-FAPI
- Application of Al18F-octreotide PET/CT in Tumors With Positive SSTR ExpressionRecruitingPhase 2/3Cancer Institute and Hospital, Chinese Academy of Medical SciencesNCT05749289Written as Al18F-octreotide
- Application of Al18F-NOTA-FAPI PET/CT in Malignant Tumors Expressing Fibroblast-activated ProteinsRecruitingPhase 2/3Cancer Institute and Hospital, Chinese Academy of Medical SciencesNCT05749302Written as Al18F-NOTA-FAPI
- Al18F-PSMA-617 and 68Ga-PSMA-617 PET/CT Imaging in the Same Group of Prostate Cancer PatientsRecruitingPhase 2/3Peking Union Medical College HospitalNCT05841992Written as Al18F-PSMA-617